Evaluation of the Proliferative Activity of Diffuse Large B-Cell Lymphoma (DLBCL) in Dogs with Respect to Patient Eligibility for Anthracycline-Based Chemotherapy

Evaluation of the Proliferative Activity of Diffuse Large B-Cell Lymphoma (DLBCL) in Dogs with Respect to Patient Eligibility for Anthracycline-Based Chemotherapy

Different types of canine lymphoma respond differently to chemotherapy and have different prognoses. Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma in dogs. Topoisomerase II alpha (TOPIIα) protein has been shown to be a proliferation marker associated with prognostic significance....

Full description

Bibliographic Details
Main Authors: Paweł Klimiuk, Wojciech Łopuszyński, Kamila Bulak, Adam Brzana
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Animals
Subjects:
malignant lymphoma
dog
cell proliferation
chemotherapy
Ki67
topoisomerase IIα
Online Access:https://www.mdpi.com/2076-2615/11/4/1183

Similar Items

Similar Items